Literature DB >> 9452460

Microtubule integrity regulates src-like and extracellular signal-regulated kinase activities in human pro-monocytic cells. Importance for interleukin-1 production.

A Schmid-Alliana1, L Menou, S Manié, H Schmid-Antomarchi, M A Millet, S Giuriato, B Ferrua, B Rossi.   

Abstract

We have demonstrated previously that microtubule depolymerization by colchicine in human monocytes induces selective production of interleukin-1 (IL-1) (Manié, S., Schmid-Alliana, A., Kubar, J., Ferrua, B., and Rossi, B. (1993) J. Biol. Chem. 268, 13675-13681). Here, we provide evidence that disruption of the microtubule structure rapidly triggers extracellular signal-regulated kinase (ERK) activation, whereas it was without effect on SAPK2 activity, which is commonly acknowledged to control pro-inflammatory cytokine production. This process involves the activation of the entire cascade including Ras, Raf-1, MEK1/2, ERK1, and ERK2. Activation of ERKs is followed by their nuclear translocation. Although other SAPK congeners might be activated upon microtubule depolymerization, the activation of ERK1 and ERK2 is mandatory for IL-1 production as shown by the blocking effect of PD 98059, a specific MEK1/2 inhibitor. Additionally, we provide evidence that microtubule disruption also induces the activation of c-Src and Hck activities. The importance of Src kinases in the mediation of the colchicine effect is underscored by the fact that CP 118556, a specific inhibitor of Src-like kinase, abrogates both the colchicine-induced ERK activation and IL-1 production. This is the first evidence that ERK activation is an absolute prerequisite for induction of this cytokine. Altogether, our data lend support to a model where the status of microtubule integrity controls the level of Src activities that subsequently activate the ERK kinase cascade, thus leading to IL-1 production.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9452460     DOI: 10.1074/jbc.273.6.3394

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  NM23/nucleoside diphosphate kinase and signal transduction.

Authors:  A S Otero
Journal:  J Bioenerg Biomembr       Date:  2000-06       Impact factor: 2.945

Review 2.  Mechanisms of Taxol resistance related to microtubules.

Authors:  George A Orr; Pascal Verdier-Pinard; Hayley McDaid; Susan Band Horwitz
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

3.  Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins.

Authors:  C K Combs; D E Johnson; S B Cannady; T M Lehman; G E Landreth
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

Review 4.  Linking cell structure to gene regulation: signaling events and expression controls on the model genes PAI-1 and CTGF.

Authors:  Rohan Samarakoon; Margarete Goppelt-Struebe; Paul J Higgins
Journal:  Cell Signal       Date:  2010-04-02       Impact factor: 4.315

5.  A small molecule, MTBT, prevents cancer cell growth by activating p38 MAPK.

Authors:  Yan Li; Xuelian Zhang; Jing Zhang; Yongzhen Li; Wei Liu; Zhen Wang; Yanchang Wang; Shuyi Si
Journal:  Anticancer Drugs       Date:  2014-04       Impact factor: 2.248

6.  Src-family kinase-p53/ Lyn p56 plays an important role in TNF-alpha-stimulated production of O2- by human neutrophils adherent to fibrinogen.

Authors:  S R Yan; M J Novak
Journal:  Inflammation       Date:  1999-04       Impact factor: 4.092

7.  Nocodazole increases the ERK activity to enhance MKP-1expression which inhibits p38 activation induced by TNF-α.

Authors:  Xiangrui Guo; Xueying Zhang; Yajing Li; Yuanyuan Guo; Jing Wang; Yan Li; Beifen Shen; Dejun Sun; Jiyan Zhang
Journal:  Mol Cell Biochem       Date:  2012-05       Impact factor: 3.396

8.  MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer.

Authors:  Madeleine J Oudin; Lucie Barbier; Claudia Schäfer; Tatsiana Kosciuk; Miles A Miller; Sangyoon Han; Oliver Jonas; Douglas A Lauffenburger; Frank B Gertler
Journal:  Mol Cancer Ther       Date:  2016-11-03       Impact factor: 6.261

9.  Extracellular signal-regulated kinase 1/2 activity is not required in mammalian cells during late G2 for timely entry into or exit from mitosis.

Authors:  Mio Shinohara; Alexei V Mikhailov; Julio A Aguirre-Ghiso; Conly L Rieder
Journal:  Mol Biol Cell       Date:  2006-10-11       Impact factor: 4.138

10.  Similar time-course of interleukin-1 beta production and extracellular-signal-regulated kinase (ERK) activation in permanent focal brain ischemic injury.

Authors:  Donald A Skifter; Peter R Allegrini; Christoph Wiessner; Anis K Mir
Journal:  Metab Brain Dis       Date:  2002-09       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.